Showing results (1-10 of 414) with videos related to
Sort By:
Pageof 42
Therapie|October 27, 2001
[Biological markers: utilization in drug development and approval]F Gueyffier, M Dib, J P BoisselJournal of Neurology|May 1, 1997
The Riluzole Early Access Programme: descriptive analysis of 844 patients in France. ALS/Riluzole Study Group IIIV Meininger, M Dib, F Aubin, et al.Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|July 23, 2005
Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzoleC Paillisse, L Lacomblez, M Dib, et al.Therapie|July 2, 2002
[Tolerance of riluzole in a phase IIIb clinical trial]L Lacomblez, M Dib, V Doppler, et al.Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|July 24, 2001
Clinical trials: the past, a lesson for the futureV MeiningerTherapie|April 27, 1999
[Note on the epistemology of clinical pharmacology: comparison with the approach of Karl Popper]J P BoisselTherapie|July 1, 1994
[Therapeutic information: how to transmit current scientific data. Group VALIDATA]J P BoisselArchives Des Maladies Du Coeur Et Des Vaisseaux|January 22, 1998
[Target population for hypertensive therapy]J P BoisselArchives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 1994
[Meta-analysis of clinical trials: values and limitations]J P BoisselPageof 42